Literature DB >> 5444059

Metabolite of (-)-trans-delta 8-tetrahydrocannabinol: identification and synthesis.

R L Foltz, A F Fentiman, F G Leighty, J L Walter, H R Drewes, W E Schwartz, T F Page, E B Truitt.   

Abstract

The major metabolite of (-)-trans-Delta(8)-tetrahydrocannabinol observed in vivo and formed by hepatic microsomes in vitro is 11-hydroxy-trans-Delta(8)-tetrahydrocannabinol. The metabolite was identified spectroscopically and was synthesized from trans-Delta(8)-tetrahydrocannabinol. In tests with rats, the metabolite produced behavioral effects similar to those imparted by Delta(8)- and Delta(9)-tetrahydrocannabinol.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5444059     DOI: 10.1126/science.168.3933.844

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  [Hashish--chemistry and problems].

Authors:  D Bieniek; W Gau; F Korte
Journal:  Naturwissenschaften       Date:  1974-03

2.  1 - and 1 ( 6 ) tetrahydrocannabinol: preliminary observations on similarities and differences in central pharmacological effects in the cat.

Authors:  M Segal; A F Kenney
Journal:  Experientia       Date:  1972-07-15

3.  Confirmation of the presence of 11-hydroxy- 9-tetrahydrocannabinol in the urine of marijuana smokers.

Authors:  E J Woodhouse
Journal:  Am J Public Health       Date:  1972-10       Impact factor: 9.308

4.  (-)- s -tetrahydrocannabinol: two novel in vitro metabolites.

Authors:  D E Maynard; O Gurny; R G Pitcher; R W Kierstead
Journal:  Experientia       Date:  1971-10-15

Review 5.  The psychopharmacology of "cannabis sativa": a review.

Authors:  L Mills; P Brawley
Journal:  Agents Actions       Date:  1972

6.  Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism.

Authors:  W D Paton; R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

7.  Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.

Authors:  L Lemberger; R Martz; B Rodda; R Forney; H Rowe
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.